- Home
- LQDT vs QURE Comparison
LQDT vs QURE Comparison
Compare LQDT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDT
- QURE
- Stock Information
- Founded
- LQDT 1999
- QURE 1998
- Country
- LQDT United States
- QURE Netherlands
- Employees
- LQDT N/A
- QURE N/A
- Industry
- LQDT Catalog/Specialty Distribution
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- LQDT Consumer Discretionary
- QURE Health Care
- Exchange
- LQDT Nasdaq
- QURE Nasdaq
- Market Cap
- LQDT 859.6M
- QURE 866.3M
- IPO Year
- LQDT 2006
- QURE 2007
- Fundamental
- Price
- LQDT $24.19
- QURE $62.77
- Analyst Decision
- LQDT Strong Buy
- QURE Strong Buy
- Analyst Count
- LQDT 2
- QURE 12
- Target Price
- LQDT $38.50
- QURE $69.67
- AVG Volume (30 Days)
- LQDT 157.2K
- QURE 7.7M
- Earning Date
- LQDT 11-20-2025
- QURE 10-29-2025
- Dividend Yield
- LQDT N/A
- QURE N/A
- EPS Growth
- LQDT 33.77
- QURE N/A
- EPS
- LQDT 0.83
- QURE N/A
- Revenue
- LQDT $465,508,000.00
- QURE $14,337,000.00
- Revenue This Year
- LQDT $31.57
- QURE N/A
- Revenue Next Year
- LQDT $2.58
- QURE $287.72
- P/E Ratio
- LQDT $29.06
- QURE N/A
- Revenue Growth
- LQDT 38.40
- QURE N/A
- 52 Week Low
- LQDT $21.23
- QURE $5.35
- 52 Week High
- LQDT $39.72
- QURE $65.14
- Technical
- Relative Strength Index (RSI)
- LQDT 41.36
- QURE 68.10
- Support Level
- LQDT $23.06
- QURE $57.64
- Resistance Level
- LQDT $24.40
- QURE $64.75
- Average True Range (ATR)
- LQDT 0.84
- QURE 4.19
- MACD
- LQDT -0.19
- QURE -0.86
- Stochastic Oscillator
- LQDT 27.22
- QURE 83.47
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.